IMPACT HEALTHCARE REIT PLC
ISIN: GB00BYXVMJ03 | LEI: 213800AX3FHPMJL4IJ53
Country: United Kingdom
The Scalpel, 18Th Floor, 52 Lime Street, EC3M 7AF London – United Kingdom
| Line item in (gbp) | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|
| Assets | N/A | 429,647,000.00 | 514,495,000.00 | 596,524,000.00 |
| Noncurrent Assets | N/A | 421,579,000.00 | 499,677,000.00 | 572,449,000.00 |
| Investment Property | N/A | 405,657,000.00 | 437,635,000.00 | 504,318,000.00 |
| Noncurrent Receivables | N/A | 15,915,000.00 | 61,948,000.00 | 68,131,000.00 |
| Noncurrent Derivative Financial Assets | N/A | 7,000.00 | 94,000.00 | 0.00 |
| Current Assets | N/A | 8,068,000.00 | 14,818,000.00 | 24,075,000.00 |
| Trade And Other Current Receivables | N/A | 89,000.00 | 1,557,000.00 | 1,181,000.00 |
| Cash and cash equivalents | 47,790,000.00 | 7,979,000.00 | 13,261,000.00 | 22,531,000.00 |
| Current Derivative Financial Assets | N/A | N/A | 0.00 | 363,000.00 |
| Equity | 340,682,000.00 | 349,521,000.00 | 394,244,000.00 | 445,920,000.00 |
| Issued Capital | N/A | 3,189,000.00 | 3,506,000.00 | 4,048,000.00 |
| Retained Earnings | N/A | 50,893,000.00 | 60,989,000.00 | 52,153,000.00 |
| Share Premium | N/A | 271,362,000.00 | 305,672,000.00 | 365,642,000.00 |
| Capital Redemption Reserve | N/A | 24,077,000.00 | 24,077,000.00 | 24,077,000.00 |
| Liabilities | N/A | 80,126,000.00 | 120,251,000.00 | 150,604,000.00 |
| Noncurrent Liabilities | N/A | 76,997,000.00 | 113,548,000.00 | 126,664,000.00 |
| Noncurrent Payables | N/A | 2,784,000.00 | 2,641,000.00 | 2,471,000.00 |
| Noncurrent Derivative Financial Liabilities | N/A | N/A | 0.00 | 1,811,000.00 |
| Longterm Borrowings | N/A | 74,213,000.00 | 110,907,000.00 | 122,382,000.00 |
| Current Liabilities | N/A | 3,129,000.00 | 6,703,000.00 | 23,940,000.00 |
| Trade And Other Current Payables | N/A | 3,129,000.00 | 6,703,000.00 | 9,126,000.00 |
| Line item in (gbp) | 01.01.2020/ 01.01.2021 |
01.01.2021/ 01.01.2022 |
01.01.2022/ 01.01.2023 |
|---|---|---|---|
| Insurance Revenue | 374,000.00 | 496,000.00 | 704,000.00 |
| Insurance Expense | 376,000.00 | 496,000.00 | 704,000.00 |
| Profit Loss From Operating Activities | 31,290,000.00 | 35,160,000.00 | 19,096,000.00 |
| Finance Income | 49,000.00 | 72,000.00 | 3,200,000.00 |
| Finance Costs | 2,556,000.00 | 3,264,000.00 | 5,408,000.00 |
| Profit Loss Before Tax | 28,783,000.00 | 31,968,000.00 | 16,888,000.00 |
| Income Tax Expense Continuing Operations | 0.00 | 0.00 | 0.00 |
| Profit (loss) | 28,783,000.00 | 31,968,000.00 | 16,888,000.00 |
| Profit Loss Attributable To Owners Of Parent | 28,783,000.00 | 31,968,000.00 | 16,888,000.00 |
| Line item in (gbp) | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|
| Profit (loss) | N/A | 28,783,000.00 | 31,968,000.00 | 16,888,000.00 |
| Adjustments For Finance Costs | N/A | 2,556,000.00 | 3,264,000.00 | 5,408,000.00 |
| Adjustments For Losses Gains On Disposal Of Noncurrent Assets | N/A | -153,000.00 | -308,000.00 | -130,000.00 |
| Cash Flows From Used In Operating Activities | N/A | 21,023,000.00 | 23,582,000.00 | 29,488,000.00 |
| Cash Advances And Loans Made To Other Parties Classified As Investing Activities | N/A | N/A | 37,500,000.00 | 0.00 |
| Interest Received Classified As Investing Activities | N/A | 49,000.00 | 2,000.00 | 3,270,000.00 |
| Cash Flows From Used In Investing Activities | N/A | -89,299,000.00 | -65,095,000.00 | -77,656,000.00 |
| Proceeds From Issuing Shares | N/A | N/A | 35,334,000.00 | 62,269,000.00 |
| Proceeds From Borrowings Classified As Financing Activities | N/A | 51,243,000.00 | 92,685,000.00 | 85,074,000.00 |
| Repayments Of Borrowings Classified As Financing Activities | N/A | 0.00 | 54,507,000.00 | 57,362,000.00 |
| Dividends Paid Classified As Financing Activities | N/A | N/A | 21,872,000.00 | 25,724,000.00 |
| Interest Paid Classified As Financing Activities | N/A | 1,261,000.00 | 1,864,000.00 | 3,281,000.00 |
| Cash Flows From Used In Financing Activities | N/A | 28,465,000.00 | 46,795,000.00 | 57,438,000.00 |
| Increase (decrease) in cash and cash equivalents after effect of exchange rate changes | N/A | -39,811,000.00 | 5,282,000.00 | 9,270,000.00 |
| Cash and cash equivalents | 47,790,000.00 | 7,979,000.00 | 13,261,000.00 | 22,531,000.00 |
Please note that some sums might not add up.
GB00BYXVMJ03
LEI213800AX3FHPMJL4IJ53
Listed Stock ExchangeKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.